Log In
BCIQ
Print this Print this
 

BI 224436

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionNon-catalytic site integrase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsHIV/AIDS
Regulatory Designation
PartnerGilead Sciences Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/10/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today